DOSSIER · 13F Holders · Q2 2026Healthcare · Pharmaceutical Preparations
ESPR
ESPERION THERAPEUTICS INC NE
200 institutions still hold ESPERION THERAPEUTICS INC NE as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 29664W105·Pharmaceutical Preparations·200 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
200 institutions reported ESPR in Q2 2026. BlackRock, Inc. leads at 17.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 10
180 more holders available. Log in →